A common narrative is that COVID-19 cost Trump re-election. We do not find supporting evidence; if anything, the pandemic helped Trump. However, we find substantial evidence that voters abandoned Trump in counties with large increases in health insurance coverage since the Affordable Care Act,...

The forces of the market and systems competition bring about economic and social convergence in Europe. There is no need for social policies at the EU level. Social harmonisation would distort migration flows and slow down the speed of economic convergence. National welfare states will be...

The eastern expansion of the EU resembles German unification in its mometousness. Whereas the latter led to a 26% increase in the population of the Federal Republic, the former will increase the population of the EU by 28% if all ten entry aspirants are accepted. A special problem will be posed...

The specificities of the workforce with a migrant background are often neglected in studies of retirement. Similarly, many studies of migration's impact on pensions often focus on aggregate outcomes - system sustainability or distributive characteristics. The present paper provides a fresh look...

In this paper we confront the role the EU traditionally plays in the domain of health with the urgent need for collective action triggered by the corona virus pandemic. In the face of such a crisis, we argue that the joint procurement, stockpiling and allocation of medical countermeasures is a...

Decisions on public health measures to contain a pandemic are often based on parameters such as expected disease burden and additional mortality due to the pandemic. Both pandemics and non-pharmaceutical interventions to fight pandemics, however, produce economic, social, and medical costs. The...

This paper provides estimates of COVID-19 effective reproduction numbers and explains their evolution for selected European countries since the start of the pandemic taking account of changes in voluntary and government mandated social distancing, incentives to comply, vaccination and the...

A non-trivial fraction of people cannot afford to buy pharmaceutical products at unregulated market prices. Therefore, the paper analyzes the public insurance of the pharmaceutical products in terms of price controls and the socially optimal third-degree price discrimination. It characterizes...

This paper investigates the short-run impact of public insurance expansion under the Affordable Care Act on out-of-pocket medical spending (OOP) and risk exposure among low-income, eligible households as well as the incidence of the cost of providing insurance. Using data from the Medical...

Although a significant number of middle and low-income countries have expanded access to subsidized health insurance, it still is unclear whether these insurance expansions improve children's health, This paper exploits quasi-random variation from an insurance expansion targeted at poor...